Medscape Today News

• Total COVID Deaths in Europe Could Exceed 2.2 Million by March: WHO WHO said on Tuesday a further 700,000 people could die from COVID-19 in Europe by March, taking the total to above 2.2 million, as it urged people to get vaccinated and to have booster shots.
  Reuters Health Information, November 23, 2021
• EU Kicks Off Debate on Need for Booster Shots to Travel European Union governments kicked off a debate on Tuesday about how long vaccines are effective against COVID-19 and whether evidence of a booster dose will be required to maintain free travel across the bloc as cases spike.
  Reuters Health Information, November 23, 2021
• Licence Deal to Provide COVID Antibody Test Tech Free to Poorer Countries A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and middle-income countries, WHO said on Tuesday.
  Reuters Health Information, November 23, 2021
• Dutch COVID-19 Patients Transferred to Germany as Hospitals Struggle The Netherlands started transporting COVID-19 patients across the border to Germany on Tuesday to ease pressure on Dutch hospitals, which are scaling back regular care to deal with a surge in coronavirus cases.
  Reuters Health Information, November 23, 2021
• Ivermectin May Halt Spread of River Blindness, Curb West Nile Virus Transmission Mass treatment with ivermectin has eliminated river blindness in two Nigerian states, according to research presented at the American Society of Tropical Medicine and Hygiene annual meeting.
  Reuters Health Information, November 23, 2021
• The Wild Turkeys Menacing US Towns Once the aim of a country-wide conservation effort, wild turkey populations have ballooned in urban and suburban areas, leading to some altercations with human residents.
  Quick Take, November 24, 2021
• At What Price Will Newer Anti-Diabetes Drugs Be Cost Effective? In low- to middle-income countries, SGLT2 inhibitors could reduce diabetes complications at lower but feasible prices; they are cost effective at current prices in people with heart or kidney disease.
  Medscape Medical News, November 24, 2021
• AHA 2021 Obicetrapib: CETP Inhibitor Impresses in LDL Lowering A new lipid-lowering agent in a class that had been written off by many is being developed by a group of academic experts, with new data showing large LDL reductions on top of high-intensity statins.
  Medscape Medical News, November 24, 2021
• OSA Linked to White Matter Hyperintensities Individuals diagnosed with obstructive sleep apnea have higher volumes of white matter hyperintensities.
  Medscape Medical News, November 24, 2021
• Nearly 1 in 5 Americans With Hypertension Taking Meds That Raise Blood Pressure One overlooked obstacle to blood pressure control may be that almost 18% of Americans with hypertension, and 15% of US adults overall, are taking medications that raise blood pressure, a new study suggests.
  Reuters Health Information, November 22, 2021
• Antihypertensive Designer Peptide Appears Safe and Effective in First Human Trial The designer peptide MANP met safety and efficacy goals for the treatment of hypertension in its first trial on human patients, researchers report.
  Reuters Health Information, November 22, 2021
• Does Vitamin D Benefit Only Those Who Are Deficient? A large Mendelian randomization analysis has shown that, among those with vitamin D deficiency, there is an association between 25(OH)D levels and all-cause mortality.
  Medscape Medical News, November 24, 2021
• Kool-Aid, Lemonade, Tang Recalled for Metal or Glass Bits Several popular powdered drink mixes from Kraft Heinz have been recalled.
  WebMD Health News, November 24, 2021
• Coffee, Smoking and Aspirin Influence Parkinson's Disease Onset Coffee drinking, aspirin use, and smoking influence the age of onset and the extent of clinical symptoms in patients with Parkinson's disease, early research suggests.
  Medscape Medical News, November 24, 2021
• Major Risk Factors for VTE After COVID Discharge Identified A new study helps pinpoint which patients with COVID-19 may benefit from extended thromboprophylaxis after they leave the hospital.
  Reuters Health Information, November 22, 2021
• 30% of Docs Say They Don't Want Own Kids 5-11 to Get COVID Vaccine Among nurses/APRNs with kids in that age group, 45% said they would not have their children vaccinated.
  Medscape Medical News, November 23, 2021
• Fueling an 'Already Raging Fire': Fifth COVID Surge Approaches As the holidays beckon and immunity wanes, both for the vaccinated and for those who've had a previous infection, not to mention the unvaccinated, the scenario according experts is serious.
  Medscape Medical News, November 23, 2021
• CTAD 2021 Gum Disease Bacteria a New Treatment Target for Alzheimer's? An oral agent used to stop gum disease suggests a "new treatment paradigm" for mild to moderate Alzheimer's disease, early research suggests.
  Medscape Medical News, November 23, 2021
• AHA 2021 Sacubitril/Valsartan May Alter Trajectory of Preclinical HFpEF The combination was linked to greater changes in left atrial volume index on MRI than valsartan alone in the setting of reduced filling pressures in a phase 2 study.
  Medscape Medical News, November 23, 2021
• Short-Acting Opioids Needed for Withdrawal in Hospitals: Experts The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to help with long-term management, say authors.
  Medscape Medical News, November 23, 2021